By Rachel Slajda ( May 14, 2013, 6:51 PM EDT) -- The Food and Drug Administration said Tuesday that it had approved labeling changes recommending lower doses for sleep aids containing zolpidem, such as Sanofi SA's Ambien, which can stay in a patient's bloodstream at high levels into the next day, making it dangerous to drive....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.